(2S,3R,4S)-1-[5-(adamantan-1-yl-methoxy)pentyl]-2-(hydroxymethyl)piperidin-3,4-diol

ID: ALA2011640

Chembl Id: CHEMBL2011640

PubChem CID: 70691536

Max Phase: Preclinical

Molecular Formula: C22H39NO4

Molecular Weight: 381.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OC[C@H]1[C@@H](O)[C@@H](O)CCN1CCCCCOCC12CC3CC(CC(C3)C1)C2

Standard InChI:  InChI=1S/C22H39NO4/c24-14-19-21(26)20(25)4-6-23(19)5-2-1-3-7-27-15-22-11-16-8-17(12-22)10-18(9-16)13-22/h16-21,24-26H,1-15H2/t16?,17?,18?,19-,20-,21+,22?/m0/s1

Standard InChI Key:  VIZUYNYAIYKSCL-DGVWQGFFSA-N

Associated Targets(Human)

GBA2 Tchem Beta-glucosidase (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ugcg Ceramide glucosyltransferase (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.56Molecular Weight (Monoisotopic): 381.2879AlogP: 2.18#Rotatable Bonds: 9
Polar Surface Area: 73.16Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.43CX Basic pKa: 8.66CX LogP: 1.59CX LogD: 0.31
Aromatic Rings: Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: 0.73

References

1. van den Berg RJ, Wennekes T, Ghisaidoobe A, Donker-Koopman WE, Strijland A, Boot RG, van der Marel GA, Aerts JM, Overkleeft HS..  (2011)  Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors.,  (7): [PMID:24900342] [10.1021/ml200050s]

Source